PSTV Projected Dividend Yield
Plus Therapeutics Inc ( NASDAQ : PSTV )Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. Co.'s main radiotherapeutic candidate, Rhenium-186 NanoLiposome is designed to target central nervous system cancers including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers by direct localized delivery utilizing approved standard-of-care tissue access. Co.'s radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere is designed to treat various solid organ cancers including primary and secondary liver cancers. 20 YEAR PERFORMANCE RESULTS |
PSTV Dividend History Detail PSTV Dividend News PSTV Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |